BLT BNO PBT ACL all up 60-120% ytd
still undervalued by us standards Lodge parners BLT peers valuatio chane 06/12 to 08/13
Alnylam Pharmaceuticals $1.5b $2.8b
Regulus Therapeutics $249m $244m
Arrowhead Research Corp $26m $116m
Silence Therapeutics $98m $113m
Tekmira Pharmaceuticals $29m $41m
BLT gone backward over this period mkt cap ~$40m
long way up from here
